Nastascia is an associate in the Mergers & Acquisitions Practice Group, and is resident in the New York office. Nastascia represents corporate clients and private equity funds in domestic and global mergers, acquisitions and equity investments in a broad range of industries.
Representation of Soaring Eagle Acquisition Corp. (NASDAQ: SRNG), a SPAC, in its US$15 billion business combination with Ginkgo Bioworks, Inc., a synthetic biology company, which uses technology to program cells for a potentially wide variety of uses, including fragrances and sweeteners, as well as mRNA vaccines and animal-free proteins.
Representation of DFP Healthcare Acquisitions Corp. (NASDAQ: DFPH, DFPHW), a SPAC, in its US$842 million business combination with The Oncology Institute, a US market-leader in value-based oncology care.
Representation of Anthem, Inc. in its acquisition of Integra MLTC, Inc., a managed long-term health care plan providing long-term care to individuals and communities in New York. The transaction is expected to close in the first half of 2022 once all regulatory approvals have been obtained.
Representation of NTT DATA, Inc., a recognized leader in global information technology services, in its acquisition of Nexient, LLC, a US-based software services firm.
Representation of Quad-C Management, Inc., a private equity firm, in its acquisition of Village Gourmet Holdco, LLC and its subsidiaries, specialty producers of fine meat and snacking options.